SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 3 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $435,606 | -8.3% | 15,800 | 0.0% | 0.06% | 0.0% |
| Q2 2023 | $474,948 | -17.0% | 15,800 | 0.0% | 0.06% | -14.1% |
| Q1 2023 | $572,434 | +11.4% | 15,800 | +9.7% | 0.07% | +10.9% |
| Q4 2022 | $513,648 | +38.1% | 14,400 | +30.9% | 0.06% | +25.5% |
| Q3 2022 | $372,000 | +17.0% | 11,000 | 0.0% | 0.05% | +27.5% |
| Q2 2022 | $318,000 | -10.7% | 11,000 | 0.0% | 0.04% | +8.1% |
| Q1 2022 | $356,000 | – | 11,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 699,432 | $35,216,000 | 4.25% |
| Provident Investment Management, Inc. | 590,269 | $29,720,000 | 4.23% |
| CAPITAL MANAGEMENT CORP /VA | 225,232 | $11,340,000 | 2.90% |
| FALCON POINT CAPITAL, LLC | 188,341 | $9,483,000 | 2.04% |
| Ranger Investment Management | 600,464 | $30,233,000 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 471,260 | $23,728,000 | 1.96% |
| KOPP INVESTMENT ADVISORS LLC | 41,700 | $2,100,000 | 1.77% |
| SHAKER INVESTMENTS LLC/OH | 49,617 | $2,498,000 | 1.54% |
| Bruce & Co., Inc. | 148,058 | $7,454,000 | 1.44% |
| Bridge City Capital, LLC | 45,843 | $2,308,000 | 1.43% |